The cell therapy market is swiftly progressing, propelled by significant breakthroughs in medical research and a growing embrace of novel treatments in various therapeutic fields. The global industry is estimated to be valued at US$ 4.8 billion in...
Conduit Pharmaceuticals Inc. announced that it has established a strategic services partnership with the formulation development CDMO Agility Life Sciences (“Agility”) to create new solid oral-dosage form products for its autoimmune pipeline...
Tris Pharma, Inc. (Tris), a biopharmaceutical company in the commercial stage, revealed encouraging topline findings from its ALLEVIATE-1 crucial Phase 3 clinical trial assessing cebranopadol, an experimental treatment, for addressing moderate-to...
Roche reported that the US Food and Drug Administration (FDA) has provided 510(k) clearance and a Clinical Laboratory Improvement Amendments of 1988 (CLIA) waiver for its cobas liat panels for multiplex testing of sexually transmitted infections...
Poxel SA, a biopharmaceutical firm at the clinical stage focusing on developing groundbreaking therapies for chronic serious diseases characterized by metabolic pathophysiology, such as metabolic dysfunction-associated steatohepatitis (MASH)...
Hoth Therapeutics, Inc., a biopharmaceutical firm centered on patients, is pleased to announce progress in its intellectual property holdings by acquiring and expanding patent applications related to its cutting-edge therapeutic pipeline...
Opella, the Consumer Healthcare division of Sanofi, announced that the US Food and Drug Administration (FDA) has removed a clinical hold on its proposed actual use trial (AUT) aimed at facilitating the transition of Cialis (tadalafil) from...
BioNxt Solutions Inc, a bioscience firm focused on cutting-edge drug delivery systems, is thrilled to share a significant achievement in its research and development progress. The firm is moving its innovative R&D tasks to the Gen-Plus Contract...
The Competition Commission approved the merger of nine entities with the pharmaceutical company Sequent Scientific Ltd (SSL). "The suggested merger entails a sequence of linked actions executed for the integration of SRL, Viyash, Symed, Appcure...
Glenmark Pharmaceuticals announced that its US division has introduced the anticoagulant Phytonadione injectable emulsion. Glenmark Pharmaceuticals Inc., USA has introduced a 10 mg/mL injectable emulsion of Phytonadione in single-dose ampules...
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")